Download this white paper to learn about two SGS developed assays used to show comparability in reactivity between the reference product and the biosimilar and to assess comparative mitogenesis potency of an insulin biosimilar.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Demonstrate Biosimilarity of Insulin Biosimilars
Related Resources
Mycoplasma Detection in Biopharmaceuticals
The detection of mycoplasma contamination is of utmost concern in bio-therapeutic and vaccine manufacturing. The two pharmacopeia techniques rely on the agar/broth culture test to detect...
New White Paper: Multiplexing in Bioanalysis
SGS scientists have validated a multiplex, bead-based immunoassay which determines nine cytokines simultaneously per sample, resulting in savings in costs, sample volume, and time. Download this...
Supplier Info Centre
For more product information visit SGS Life Science Services.